Momentive Puts Formaldehyde Unit On Block

Momentive Performance Materials Holdings has put its formaldehyde and resins unit on the block and the unit could be valued at between $800 million to $1 billion, several sources familiar with the matter said.

Momentive, owned by Apollo Global Management, is trying to shed the business before an IPO, those sources said. It is likely to attract interest from private equity firms, one of the sources said.

In the first quarter, the company's formaldehyde and forest products resins unit had earnings before interest, taxes, depreciation and amortization of around $45 million.

Morgan Stanley and Goldman Sachs are representing Momentive in the sale, the sources said.

Momentive filed in April to raise up to $862.5 million in its IPO. The company was formed last year when private equity company Apollo merged its two specialty chemicals companies - Hexion Specialty Chemicals and Momentive.

Apollo, Morgan Stanley and Goldman Sachs declined to comment.

 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.